MedTrace Logo

The Prevalence and Risk Factors of Coagulopathy in Pediatric Epilepsy Surgery Patients

NCT05675254 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 494

Last updated 2023-01-09

No results posted yet for this study

Summary

The hematologic consequences of novel Anti-seizure medications (ASMs) are rarely reported.

Whether coagulation dysfunctions increase the risk of peri-operative bleeding remains controversial.

The research is performed to investigated the incidence and risk factors of preoperative coagulation dysfunction in children undergoing surgery for epilepsy and their impact on surgery.

Conditions

  • Epilepsy in Children
  • Coagulation and Hemorrhagic Disorders
  • Epilepsy; Seizure
  • Antiepileptic Adverse Reaction

Sponsors & Collaborators

  • Children's Hospital of Fudan University

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2022-12-24
Completion
2022-12-24

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05675254 on ClinicalTrials.gov